A 53-year-old man underwent an esophagogastroduodenoscopy that showed a 20-mm subepithelial lesion in the middle gastric body. Endoscopic ultrasound revealed a hypoechoic mass located in the submucosa. Biopsy specimens revealed a benign gastric mucosa with severe lymphocytic infiltration in the submucosa. Malignant lymphoma or gastric cancer with lymphoid stroma was suspected. We performed endoscopic submucosal dissection for definitive diagnosis. Histological examination showed undifferentiated adenocarcinoma, which showed positive Epstein–Barr virus-encoded RNA in situ hybridization results, invading the submucosa mixed with dense lymphocytic infiltration. Thus, Epstein–Barr virus-positive gastric cancer with lymphoid stroma was diagnosed. Gastric cancer with lymphoid stroma is a rare subtype of gastric cancer, which is associated with Epstein–Barr virus infection; it sometimes appears as a subepithelial lesion, which makes it difficult to diagnose using standard biopsy. Endoscopic submucosal dissection was useful in obtaining a sufficient tissue for full histological assessment, including immunostaining.
Gastric cancer Epstein–Barr virus Subepithelial lesion Endoscopic submucosal dissection
This is a preview of subscription content, log in to check access
Compliance with ethical standards
Conflict of interest
Minoru Kato, Yoshito Hayashi, Kenji Fukumoto, Kengo Nagai, Yoshiki Tsujii, Shinichiro Sinzaki, Hideki Iijima, and Tetsuo Takehara declare that they have no conflict of interest.
Human and animal rights statements
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent was obtained from all patients for being included in the study.
Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38:232–43.CrossRefPubMedGoogle Scholar
Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein–Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377–80.PubMedGoogle Scholar
Shin DH, Kim GH, Lee BE, et al. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Surg Endosc. 2017;31:4156–64.CrossRefPubMedGoogle Scholar
Zhang XC, Li QL, Yu YF, et al. Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis. Surg Endosc. 2016;30:2431–41.CrossRefPubMedGoogle Scholar
Kang GH, Lee S, Kim WH, et al. Epstein–Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitute CpG island. Am J Pathol. 2002;160:787–94.CrossRefPubMedPubMedCentralGoogle Scholar
Kaizaki Y, Sakurai S, Chong JM, et al. Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma. Gastric Cancer. 1999;2:101–8.CrossRefPubMedGoogle Scholar
Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein–Barr virus-related early gastric carcinoma: a case–control study. Pathol Int. 1997;47:360–7.CrossRefPubMedGoogle Scholar
Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRefGoogle Scholar
Lim H, Lee SI, Lee JH, et al. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793–801.CrossRefPubMedGoogle Scholar
Tokunaga M, Land CE. Epstein–Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomark Prev. 1998;7:449–50.Google Scholar
Park JH, Kim EK, Kim YH, et al. Epstein–Barr virus positivity, not mismatch repair deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer. 2016;19:1041–51.CrossRefPubMedGoogle Scholar
Gromski MA, Miller CA, Lee SH, et al. Gastric lymphoepithelioma-like carcinoma mimicking a subepithelial lesion treated by endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:419–21.CrossRefPubMedGoogle Scholar
Lee HL, Kim DC, Lee SP, et al. Treatment of Epstein–Barr virus-associated gastric carcinoma with endoscopic submucosal dissection. Gastrointest Endosc. 2012;76:913–5.CrossRefPubMedGoogle Scholar
Lee JY, Kim KM, Min BH, et al. Epstein–Barr virus-associated lymphoepithelioma-like early gastric carcinomas and endoscopic submucosal dissection. World J Gastroenterol. 2014;20:1365–70.CrossRefPubMedPubMedCentralGoogle Scholar
Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein–Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol. 2005;40:570–7.CrossRefPubMedGoogle Scholar
Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein–Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77:1998–2004.CrossRefPubMedGoogle Scholar